| Name | AMG-386,Trebananib |
|---|
| Description | Trebananib (2xCon4C; AMG 386), a non-VEGF-dependent angiogenesis pathway inhibitor, is a peptide-Fc fusion protein that neutralises the interaction between angiopoietins-1/2 and the Tie2 receptor, plus FOLFIRI. Trebananib can be used to research anticancer and ocular neovascular diseases[1][2]. |
|---|---|
| Related Catalog |
| No Any Chemical & Physical Properties |